Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors

被引：5
|
作者：
Valuev-Elliston, V. T. [1 ]
Ivanov, A. V. [1 ]
Orlinson, B. S. [2 ]
Gerasimov, E. N. [2 ]
Brunilina, L. L. [2 ]
Kochetkov, S. N. [1 ]
Novakov, I. A. [2 ]
Navrotskii, M. B. [2 ]
机构：
[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia
[2] Volgograd State Tech Univ, Volgograd, Russia
来源：
PHARMACEUTICAL CHEMISTRY JOURNAL | 2012年 / 46卷 / 07期
关键词：
6-benzylisocytosine derivatives; HIV-1 reverse transcriptase inhibitors; ANTI-HIV-1; ACTIVITY; POTENT; AGENTS; FAMILY;
D O I：
10.1007/s11094-012-0808-y
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
New 6-benzylisocytosine derivatives were synthesized by aminolysis of 6-benzyl-2-(methylsulfanyl)pyrimidin-4(3H)-ones with aliphatic aromatic and cage-structured amines. Some of the synthesized compounds appeared to be effective HIV-1 reverse transcriptase inhibitors. Among these, 6-(2,6-difluorobenzyl)-5-methyl-2-[(2-phenylethyl)amino]pyrimidin-4(3H)-one showed the most pronounced inhibitory properties, being nine times more effective than the reference anti-HIV drug nevirapine.
引用
收藏
页码：397 / 401
页数：5
相关论文
共 50 条
  • [21] Conformational preferences of non-nucleoside HIV-1 reverse transcriptase inhibitors
    Parreira, RLT
    Abrahao, O
    Galembeck, SE
    TETRAHEDRON, 2001, 57 (16) : 3243 - 3253
  • [22] Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Ruiz-Caro, J
    Basavapathruni, A
    Kim, JT
    Bailey, CM
    Wang, LG
    Anderson, KS
    Hamilton, AD
    Jorgensen, WL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 668 - 671
  • [23] HIV-1 reverse transcriptase resistance to non-nucleoside inhibitors.
    Spence, RA
    Johnson, KA
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : MP356 - MP356
  • [24] Effect of non-nucleoside reverse transcriptase inhibitors on the HIV-1 reverse transcriptase associated ribonuclease H activity
    Tramontano, E
    Esposito, F
    Piras, A
    La Colla, P
    ANTIVIRAL RESEARCH, 2005, 65 (03) : A51 - A51
  • [25] Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    Famiglini, Valeria
    Silvestri, Romano
    MOLECULES, 2016, 21 (02):
  • [26] Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Chan, JH
    Freeman, GA
    Tidwell, JH
    Romines, KR
    Schaller, LT
    Cowan, JR
    Gonzales, SS
    Lowell, GS
    Andrews, CW
    Reynolds, DJ
    St Clair, M
    Hazen, RJ
    Ferris, RG
    Creech, KL
    Roberts, GB
    Short, SA
    Weaver, K
    Koszalka, GW
    Boone, LR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1175 - 1182
  • [27] Halolactones are potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Han, Xin
    Wu, Haoming
    Dong, Chune
    Tien, Po
    Xie, Wei
    Wu, Shuwen
    Zhou, Hai-Bing
    RSC ADVANCES, 2015, 5 (13): : 10005 - 10013
  • [28] Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors
    Deng, BL
    Hartman, TL
    Buckheit, RW
    Pannecouque, C
    De Clercq, E
    Fanwick, PE
    Cushman, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 6140 - 6155
  • [29] The synthesis of several tritiated non-nucleoside, HIV-1 reverse transcriptase inhibitors.
    Hamill, TG
    Brenner, NJ
    Eng, W
    Burns, HD
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (04): : 319 - 327
  • [30] Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Wu, Hai-Qiu
    Yao, Jin
    He, Qiu-Qin
    Chen, Wen-Xue
    Chen, Fen-Er
    Pannecouque, Christophe
    De Clercq, Erik
    Daelemans, Dirk
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (03) : 624 - 631
12345